The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation
- 1 February 1999
- Vol. 17 (7-8), 893-903
- https://doi.org/10.1016/s0264-410x(98)00275-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genesNature Biotechnology, 1997
- Construction and Characterization of a Recombinant Vaccinia Virus Expressing Murine Intercellular Adhesion Molecule-1: Induction and Potentiation of Antitumor ResponsesHuman Gene Therapy, 1997
- Cloning and Characterization of the Genes Encoding the Murine Homoloties of the Human Melanoma Antigens MARTI and gp100Journal of Immunotherapy, 1997
- Therapeutic Antitumor Response After Immunization with an Admixture of Recombinant Vaccinia Viruses Expressing a Modified MUC1 Gene and the Murine T-Cell Costimulatory Molecule B7Journal of Immunotherapy, 1997
- B7-mediated costimulation and the immune responseBlood Reviews, 1996
- A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primateInternational Journal of Cancer, 1995
- CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.The Journal of Experimental Medicine, 1993
- Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus VaccineJNCI Journal of the National Cancer Institute, 1992
- Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virusVaccine, 1991
- A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)International Journal of Cancer, 1991